Suppr超能文献

过氧化物酶体增殖物激活受体在肝脏疾病中的作用概述

An Overview of the Role of Peroxisome Proliferator-activated Receptors in Liver Diseases.

作者信息

Changizi Zahra, Kajbaf Forough, Moslehi Azam

机构信息

Cellular and Molecular Research Center, Qom University of Medical Sciences, Qom, Iran.

Veterinary Department, Faculty of Agriculture, Islamic Azad University, Shoushtar Branch, Shoushtar, Iran.

出版信息

J Clin Transl Hepatol. 2023 Dec 28;11(7):1542-1552. doi: 10.14218/JCTH.2023.00334. Epub 2023 Nov 15.

Abstract

Peroxisome proliferator-activated receptors (PPARs) are a superfamily of nuclear transcription receptors, consisting of PPARα, PPARγ, and PPARβ/δ, which are highly expressed in the liver. They control and modulate the expression of a large number of genes involved in metabolism and energy homeostasis, oxidative stress, inflammation, and even apoptosis in the liver. Therefore, they have critical roles in the pathophysiology of hepatic diseases. This review provides a general insight into the role of PPARs in liver diseases and some of their agonists in the clinic.

摘要

过氧化物酶体增殖物激活受体(PPARs)是核转录受体超家族,由PPARα、PPARγ和PPARβ/δ组成,在肝脏中高度表达。它们控制和调节大量参与肝脏代谢、能量稳态、氧化应激、炎症甚至凋亡的基因的表达。因此,它们在肝脏疾病的病理生理学中起着关键作用。本综述全面介绍了PPARs在肝脏疾病中的作用及其一些激动剂在临床上的应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验